Avantor, Inc. (NYSE:AVTR) Shares Sold by CenterBook Partners LP

CenterBook Partners LP cut its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 19.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,862 shares of the company's stock after selling 17,325 shares during the quarter. CenterBook Partners LP's holdings in Avantor were worth $1,493,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in AVTR. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock valued at $26,000 after buying an additional 625 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock valued at $34,000 after buying an additional 830 shares during the period. Global Retirement Partners LLC lifted its stake in Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock valued at $52,000 after acquiring an additional 1,067 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after acquiring an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new stake in Avantor during the fourth quarter valued at approximately $65,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Analyst Upgrades and Downgrades

AVTR has been the topic of a number of recent analyst reports. Royal Bank of Canada decreased their target price on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a report on Monday, February 10th. Cowen restated a "buy" rating on shares of Avantor in a research report on Tuesday, March 18th. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Barclays reduced their price objective on Avantor from $23.00 to $18.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Finally, Stifel Nicolaus reduced their price target on shares of Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research report on Monday, February 10th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $25.08.

Remove Ads

Avantor Trading Down 0.7 %

Shares of AVTR traded down $0.11 during trading hours on Wednesday, hitting $15.29. 2,589,567 shares of the stock traded hands, compared to its average volume of 7,572,962. Avantor, Inc. has a 1-year low of $13.80 and a 1-year high of $28.00. The firm has a market capitalization of $10.42 billion, a PE ratio of 14.70, a price-to-earnings-growth ratio of 1.55 and a beta of 1.24. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The business has a fifty day moving average of $16.54 and a 200-day moving average of $20.33.

Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the business posted $0.22 earnings per share. Analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Activity at Avantor

In related news, EVP James Bramwell sold 3,758 shares of the business's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the transaction, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.12. This represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.